Pendred syndrome is the association between congenital sensorineural deafness and goitre. The disorder is characterised by the incomplete discharge of radioiodide from a primed thyroid following perchlorate challenge.
Pendred syndrome, the association of goitre and congenital hearing loss, was first noted by Vaughan Pendred in 1896 in two sisters,' but the disorder was only more widely recognised following the reports of further sibships by Brain in 1927.2 It is inherited as an autosomal recessive trait and has recently been mapped to 7q31 coincident with the non-syndromic deafness locus DFNB4. 3 Fraser,5 in a study of a larger population based sample, concluded that Pendred syndrome characteristically segregated as an autosomal recessive disorder. The proportion of the severely hearing impaired population affected by Pendred syndrome remains uncertain, but it is likely to be a condition that is significantly underdiagnosed. Phenotypic variability, both between and within sibships, has been noted. 6 Hence, while prelingual hearing loss is a frequent feature of Pendred syndrome, the goitre, typically pubertal in onset, may vary significantly in size, even within families. Although raised levels of thyroid stimulating hormone (TSH) and reduced levels of thyroglobulin have been reported,7 the majority of patients with Pendred syndrome are clinically and biochemically euthyroid. The biochemical defects leading to Pendred syndrome remain unclear. However, Morgans and Trotter8 noted an abnormality of iodide handling by the thyroid glands of affected patients. In people affected by Pendred syndrome, between 10 and 80% of accumulated iodide is discharged on the administration of perchlorate. In a normal thyroid, iodide ions are actively transported into the cells and covalently linked to thyroglobulin following oxidation, a process involving thyroid peroxidase (TPO).9 Homozygous mutations in the TPO gene, located on chromosome 2, lead to the absence of peroxidase activity and the clinical disorder known as total iodide organification defect (TIOD 
METHODS
PCR products were amplified from 40 ng of genomic DNA using fluorescently labelled primers for markers D7S501, D7S496, and D7S523 and were analysed on a 6% denaturing acrylamide gel on the ABI 373 automated sequencer using the ABI software GenescanTM and GenotyperTm. Ten microlitre reactions with 0.5 U Taq polymerase (Advanced Biotechnologies), buffered by 50 mmol/l KCI, 10 mmol/l Tris HCI, pH 9, and varying concentrations of MgCl2, were carried out in a 96 well plate on an MJ Research Peltier thermal cycler. The genotypes for D7S692 were generated from 40 ng of genomic DNA using a y33P radiolabelled primer" in 10 gl PCR using the same buffering system as above. D7S692 was taken through 26 cycles of 55°C for 30 seconds, 72°C for 30 seconds, and 94°C for 30 seconds. D7S525 was amplified as for D7S692 but the annealing temperature was raised to 61°C and the number of cycles was lowered to 24 . Each reaction was carried out in 0.5 ml microfuge tubes on a Biometra TRIO Thermoblock with a liquid paraffin overlay. The products of these PCR reactions were electrophoresed on a 6% denaturing acrylamide gel, dried on to 3MM Whatman paper, and exposed to x ray film overnight.
LINKAGE ANALYSIS
Pairwise lod scores between the markers and the disease were calculated using the MLINK option of FASTLINK version 2.2 of the LINKAGE computer package run on a SUN O S 5.4 microsystem. Homogeneity tests were carried out using HOMOG'2 and tests for allelic association using the HRRLAMB.'3 The linkage calculations assume Pendred syndrome to be a fully penetrant autosomal recessive disorder with a disease allele frequency of 0.1%.
Allelic frequencies were estimated from the distribution in families in the present data set. No new mutations were allowed and equal male and female recombination rates were used. Figure 1 Linkage map of the microsatellite markers from chromosome 7q31. Genetic distances are indicated in centimorgans (cM). Loci were placed using the FLIPS option of CRIMAP on the published order. 4 In a test for genetic heterogeneity given linkage (HOMOG), a (the proportion of families linked to that marker) equalled 1.0 at 0 =0.0 for D7S496 and D7S692, and thus we found no evidence for genetic heterogeneity within our cohort of families. Allelic association was not detected at any of the five loci within the linkage interval. For example, at D7S496 in a chi-square test of transmitted against nontransmitted alleles X2=4.8, P=0.44.
Discussion
Genetic linkage of Pendred syndrome to 7q31 has now been reported in a total of 19 independent families, including two originally from Asia and three residing in Israel.3 4 In addition to the geographical separation of these families, detailed haplotype analysis suggests that the Pendred syndrome gene mutations have arisen independently. The lack of absolute allelic association for any marker from the linked region further supports the absence of a major founder effect to explain both the prevalence and homogeneity in Pendred syndrome between populations.
The presence of recombinations at both D7S501 and D7S523 within the five new families reported here supports the evidence previously published that Pendred syndrome maps to the interval D7S501-D7S523. Family 28 shows a recombination event at D7S525 and this allows us to refine the linkage region for Pendred syndrome to a 2.5 cM interval flanked by markers D7S501 and D7S525 (fig 1) . The appearance of five recombinations at D7S501 within the cohort of families suggests that with the development of new markers between D7S501 and D7S496 the linkage interval for Pendred syndrome could be further refined.
The appearance of affected cousins, III.2 and III.4 in family 27 (fig 2B) , the offspring of non-consanguineous parents, suggests that mutant alleles for Pendred syndrome may be more prevalent than previously considered as three independent disease bearing haplotypes are identified within this family.
Marked genetic heterogeneity is found in both syndromic and non-syndromic hearing loss. Although at least nine genetically distinct forms of autosomal recessive hearing impairment have been mapped,"'-3 typically by a search for autozygosity using isolated consanguineous families, no genes have yet been 
